Wang, W., Cortes, J. E., Tang, G., Khoury, J. D., Wang, S., Bueso-Ramos, C. E., . . . Hu, S. (2016). Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood.
Citação norma ChicagoWang, Wei, et al. "Risk Stratification of Chromosomal Abnormalities in Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitor Therapy." Blood 2016.
Citação norma MLAWang, Wei, et al. "Risk Stratification of Chromosomal Abnormalities in Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitor Therapy." Blood 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.